Skip to main content

AusPAR: Fluticasone furoate / umeclidinium / vilanterol

Australian Public Assessment Report
Device/Product Name
Trelegy Ellipta
Active ingredients
Fluticasone furoate / umeclidinium / vilanterol
AusPAR Date
Published
Submission Number
PM-2020-01842-1-5
Submission Type
Extension of indications and major variation (new strength)
Decision
Approved

Help us improve the Therapeutic Goods Administration site